Maverick Total Disc Replacement in a 'Real World' Patient Population

NCT ID: NCT01338493

Last Updated: 2016-01-28

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

139 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-02-28

Study Completion Date

2013-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary purpose of the study is to document the reduction of disability after Maverick total disc replacement surgery in a 'real-world' patient population requiring disc replacement.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Degenerative Disc Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

lumbar spinal arthroplasty + Maverick™

Patients requiring total disc replacement

lumbar spinal arthroplasty + Maverick™

Intervention Type PROCEDURE

All patients will be subjected to a lumbar spinal arthroplasty. The anterior lumbar spine is approached through either a transperitoneal or retroperitoneal exposure. A complete anterior discectomy is performed and the Maverick™ Artificial Disc System is inserted to replace the damaged lumbar intervertebral disc.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

lumbar spinal arthroplasty + Maverick™

All patients will be subjected to a lumbar spinal arthroplasty. The anterior lumbar spine is approached through either a transperitoneal or retroperitoneal exposure. A complete anterior discectomy is performed and the Maverick™ Artificial Disc System is inserted to replace the damaged lumbar intervertebral disc.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Degenerative Disc Disease (DDD) defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies
* Foraminal stenosis due to loss of disc height
* Back pain and/or leg pain.

Exclusion Criteria

* Spondylolisthesis at the affected or adjacent level
* Posterior facet joint damage and/or disease at the affected level, including facet osteoarthritis, pars fracture and prior laminectomy
* Obesity
* Osteoporosis
* Metallic allergy to cobalt-chromium-molybdenum alloys
* Psychosis
* Infection
* Spinal canal stenosis
* Overlying thoracolumbar kyphosis
* Systemic infection or infection at the site of surgery
* Osteopenia, osteoporosis, or osteomalacia to a degree that spinal instrumentation would be contraindicated
* Diseases of bone metabolism
* Pregnancy
* Signs of local inflammation
* Fever or Leukocytosis
* Grossly distorted anatomy caused by congenital abnormalities
* Any other medical or surgical condition which would preclude the potential benefit of spinal implant surgery, such as the presence of congenital abnormalities, elevation of sedimentation rate unexplained by other diseases, elevation of white blood count (WBC), or a marked left shift in the WBC differential count (this also includes: spinal active oncology pathology; not healed fracture at treated or adjacent level)
* Any case where the implants or components selected would be too large or too small to achieve a successful result
* Any patient in which implant utilization would interfere with anatomical structures or expected physiological performance
* Any patient unwilling to follow postoperative instructions.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medtronic Spinal and Biologics

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jean-Charles Le Huec, Prof.

Role: PRINCIPAL_INVESTIGATOR

CHU Pellegrin Tripode

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Montreal General Hospital

Québec, , Canada

Site Status

CHU Pellegrin Tripode

Bordeaux, , France

Site Status

CH Antoine Béclère - Service de Chirurgie Orthopédique

Clamart, , France

Site Status

Service de Chirurgie Orthopédique, AP-HP, Hôpital Beaujon

Clichy, , France

Site Status

Clinique de Neurochirurgie Hôpital Roger Salengro

Lille, , France

Site Status

CH La Timone

Marseille, , France

Site Status

CH de Meulan - Service de Chirurgie Orthopédique

Meulan-en-Yvelines, , France

Site Status

Service de Neurochirurgie Hôpital Nice

Nice, , France

Site Status

CH Lariboisière, Service de Neurochirurgie

Paris, , France

Site Status

Clinique du Cours Dillon

Toulouse, , France

Site Status

Charité Berlin - Klinik für Orthopädie

Berlin, , Germany

Site Status

Universitätsklinikum Magdeburg

Magdeburg, , Germany

Site Status

Praxis für Orthopädie und Neurochirurgie Potsdam

Potsdam, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada France Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Maverick Global Registry

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Restore CLINICAL TRIAL
NCT01609374 UNKNOWN NA